Growth Metrics

Jazz Pharmaceuticals (JAZZ) Share-based Compensation Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 206.26%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -69.95%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.18%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.66%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 23.70%
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn 10.04%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.04%
Dec 31, 2025 0.95%
Sep 30, 2025 47.46%
Jun 30, 2025 13.77%
Mar 31, 2025 10.19%
Dec 31, 2024 32.58%
Sep 30, 2024 6.50%
Jun 30, 2024 -7.78%
Mar 31, 2024 9.03%
Dec 31, 2023 -14.00%
Sep 30, 2023 -1.00%
Jun 30, 2023 14.43%
Mar 31, 2023 12.55%
Dec 31, 2022 15.89%
Sep 30, 2022 6.47%
Jun 30, 2022 11.47%
Mar 31, 2022 45.19%
Dec 31, 2021 69.26%
Sep 30, 2021 75.38%
Jun 30, 2021 57.37%
Mar 31, 2021 20.35%
Dec 31, 2020 21.00%
Sep 30, 2020 5.46%
Jun 30, 2020 8.18%
Mar 31, 2020 4.00%
Dec 31, 2019 -2.94%
Sep 30, 2019 14.67%
Jun 30, 2019 7.51%
Mar 31, 2019 13.37%
Dec 31, 2018 -2.19%
Sep 30, 2018 -7.46%
Jun 30, 2018 -3.48%
Mar 31, 2018 -3.53%
Dec 31, 2017 12.52%
Sep 30, 2017 9.05%
Jun 30, 2017 7.18%
Mar 31, 2017 4.18%
Dec 31, 2016 -0.15%
Sep 30, 2016 7.61%
Jun 30, 2016 9.15%
Mar 31, 2016 16.16%
Dec 31, 2015 27.85%
Sep 30, 2015 26.65%
Jun 30, 2015 25.59%
Mar 31, 2015 50.70%
Sep 30, 2014 -43.21%
Jun 30, 2014 -8.44%
Mar 31, 2014 57.76%
Sep 30, 2013 386.07%
Jun 30, 2013 285.37%
Mar 31, 2013 166.90%
Dec 31, 2012 7.60%
Sep 30, 2012 106.95%
Jun 30, 2012 53.97%
Mar 31, 2012 4.22%
Dec 31, 2011 224.44%
Sep 30, 2011 46.76%